Table 1.
Participant Characteristics, N=144
| Variable | N(%) or Mean(SD) |
|---|---|
|
Sociodemographic and smoking variables | |
| Gender (female), N(%) | 72 (50.0%) |
| Race/ethnicity (minority),a N(%) | 48 (33.3%) |
| Age (years), M(SD) | 58.7 (8.9) |
| Education (≤ high school degree), N(%) | 35 (24.3%) |
| Employment status (unemployed/retired), N(%) | 62 (41.6%) |
| Cigarettes/day, M(SD) | 14.9 (7.7) |
| Years smoking (years), M(SD) | 40.8 (11.1) |
| Nicotine dependence (FTND score), M(SD) | 4.6 (2.1) |
|
Cancer-related disease factors | |
| Tumor site (smoking-related),b N(%) | 29 (20.0%) |
| Cancer treatment (current, past month),c N(%) | 59 (41.0%) |
| Time since diagnosis (months), M(SD) | 19.8 (18.9) |
| <1 year, n(%) | 70 (47.0%) |
| ≥1 year and <4 years, n(%) | 62 (41.6%) |
| ≥4 years, n(%) | 17 (11.4%) |
| Health-related quality of life (SF-12 score),d M(SD) | 36.9 (6.0) |
|
Smoking cessation treatment outcomes | |
| Medication adherence (adherent),e N(%) | 81 (56.3%) |
| Counseling adherence (adherent), N(%) | 107 (74.3%) |
| 12-week abstinence (abstinent), N(%) | 56 (38.9%) |
Racial/ethnic minority included: 41 (27.5%) Black/African American, 1 (0.7%) American Indian/Alaska Native, 1 (0.7%) more than one race, 3 (2.0%) and unknown/not reported; 6 (4.0%) participants reported that they were Hispanic/Latino.
Smoking-related tumor sites included lung, head and neck, and throat.
Cancer treatment included surgery, chemotherapy, radiation treatment, and hormone therapy.
The SF-12 scores in this sample ranged from 20-47 (out of a possible range of 12-47); higher scores indicate greater health-related quality of life.
N=140: Four participants who completed the baseline and Pre-quit sessions did not attend any follow-up visits and did not report medication u.
Abbreviations: M, mean. SD, standard deviation. FTND, Fagerström Test of Nicotine Dependence. SF-12, 12-item Short Form Health Survey.